Filter
445
Filtered Results: 445
Text search:
substandard
medicines
Featured
Recommendations
34
New Publications
135
Language
Document type
No document type
233
Studies & Reports
94
Guidelines
46
Strategic & Response Plan
27
Manuals
22
Fact sheets
8
Training Material
6
Situation Updates
6
Infographics
2
Online Courses
1
Countries / Regions
Nigeria
16
Global
16
Kenya
15
Western and Central Europe
15
Ethiopia
15
Uganda
13
Sierra Leone
12
Malawi
12
India
11
Tanzania
9
South Africa
9
Syria
8
Bangladesh
8
Liberia
8
Nepal
7
Rwanda
7
Africa
7
South–East Asia Region
6
Zambia
6
Myanmar / Burma
6
Ghana
5
Cambodia
5
Congo, Democratic Republic of
5
Lesotho
4
Zimbabwe
4
Latin America and the Carribbean
4
Vietnam
4
Eswatini/ Swaziland
4
Philippines
3
Mozambique
3
Asia
3
Namibia
3
Thailand
2
Ukraine
2
Cameroon
2
Guinea
2
Haiti
2
Jordan
2
Lebanon
2
Eastern Europe
2
Palestine
2
Poland
2
Pakistan
2
North Macedonia
1
Canada
1
Laos
1
Burundi
1
Peru
1
Venezuela
1
Hungary
1
Germany
1
West and Central Africa
1
Middle East and North Africa
1
Israel
1
East and Southern Africa
1
Egypt
1
Sudan
1
Central African Republic
1
Botswana
1
South Sudan
1
Indonesia
1
Iraq
1
Authors & Publishers
Publication Years
Category
Countries
180
Public Health
22
Clinical Guidelines
21
Key Resources
17
Pharmacy & Technologies
13
Women & Child Health
10
Capacity Building
6
Annual Report MEDBOX
1
Toolboxes
AMR
64
TB
38
Pharmacy
34
HIV
23
COVID-19
20
Malaria
19
Conflict
14
Mental Health
10
Refugee
10
Ebola & Marburg
9
NTDs
9
Global Health Education
9
Rapid Response
8
Caregiver
8
Disability
5
Planetary Health
5
Natural Hazards
3
Polio
2
Specific Hazards
1
Cholera
1
Social Ethics
1
Health Financing Toolbox
1
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has...
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli...
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli...
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o...
Access to safe, effective and quality-assured health products and technologies is crucial for achieving universal health coverage and primary health care goals. The continued growth of the aging population; increasing burden of noncommunicable diseases; growing burden of mental health issues; climat...
Antimicrobial resistance (AMR) is a serious public health concern with economic, social and political implications that are global in scope, and cross all environmental and ethnic boundaries. As a global threat, AMR risks the achievements of modern medicine, and has the po...
Formularies are lists of antibiotics that are suggested for certain healthcare settings. In developing a recommended formulary, countries should consider the needs of patients and facilities where they receive care. For example, clinicians in rural or primary health centers may need wide access to f...
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
An evaluation of the prescribing patterns for under-five patients at a Tertiary Paediatric Hospital in Sierra Leone. J Basic Clin Pharma 2015;6:109-14.
Handbook of HUMANITARIAN HEALTH CARE LOGISTICS Designing the Supply Network and Managing the Flows of Information and Health Care Goods in Humanitarian Assistance during Complex Political Emergencies
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was...
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a...
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
High prices, hard-to-access human insulin, few insulin producers, and weak health systems are just some of the barriers that people with diabetes face a century after insulin was discovered, WHO notes in a new report
